Casasnovas, Carlos
Ruiz, Montserrat
Schlüter, Agatha
Naudí, Alba
Fourcade, Stéphane
Veciana, Misericordia
Castañer, Sara
Albertí, Antonia
Bargalló, Nuria
Johnson, Maria
Raymond, Gerald V.
Fatemi, Ali
Moser, Ann B.
Villarroya, Francesc
Portero-Otín, Manuel
Artuch, Rafael
Pamplona, Reinald
Pujol, Aurora http://orcid.org/0000-0002-9606-0600
Funding for this research was provided by:
Ministerio de Sanidad, Servicios Sociales e Igualdad (EC10-137)
Instituto de Salud Carlos III (ICI14/0076, Miguel Servet Program CPII16/00016)
European Commission (Leukotreat FP7-241622)
Autonomous Government of Catalonia-AGAUR (2014SGR1430)
autonomous Government of Catalonia - AGAUR (2017SGR1206)
Ministerio de Ciencia e Innovación (BFU2009-11879/BFI)
This article is maintained by: Elsevier
Article Title: Biomarker Identification, Safety, and Efficacy of High-Dose Antioxidants for Adrenomyeloneuropathy: a Phase II Pilot Study
Journal Title: Neurotherapeutics
CrossRef DOI link to publisher maintained version: https://doi.org/10.1007/s13311-019-00735-2
Content Type: article
Copyright: Copyright © 2019 The Author(s). Published by Elsevier B.V. All rights reserved.